Enliven Therapeutics
ELVN
ELVN
124 hedge funds and large institutions have $1.19B invested in Enliven Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 23 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 121 → 124 (+3)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Holders
124
Holding in Top 10
7
Calls
–
Puts
$14K
Top Buyers
| 1 | +$26.4M | |
| 2 | +$24.3M | |
| 3 | +$21.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$13.7M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$11M | |
| 3 | -$7.1M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.7M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.22M |
